Cholic acid-Biotin

Cat. No.: HY-N0324F Purity: ≥95.0%: FAQs
Data Sheet SDS COA Handling Instructions Technical Support

Cholic acid-Biotin is a biotin-labeled Cholic acid (HY-N0324). Cholic acid is a major primary bile acid produced in the liver and usually conjugated with glycine or taurine. It facilitates fat absorption and cholesterol excretion. Cholic acid has orally activity.

For research use only. We do not sell to patients.

Cholic acid-Biotin Chemical Structure

Size	Stock	Quantity
Free Sample (0.1 - 0.5 mg)	Apply Now
5 mg	In-stock	Estimated Time of Arrival: December 31
10 mg	In-stock	Estimated Time of Arrival: December 31
25 mg	In-stock	Estimated Time of Arrival: December 31
50 mg	In-stock	Estimated Time of Arrival: December 31
100 mg	In-stock	Estimated Time of Arrival: December 31
200 mg	Get quote
500 mg	Get quote

or Bulk Inquiry

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 1 publication(s) in Google Scholar

Other Forms of Cholic acid-Biotin:

Cholic acid In-stock

Featured Recommendations

•Related Small Molecules:

•Related Proteins:

Biological Activity
Purity & Documentation
References
Customer Review

Description	Cholic acid-Biotin is a biotin-labeled Cholic acid (HY-N0324). Cholic acid is a major primary bile acid produced in the liver and usually conjugated with glycine or taurine. It facilitates fat absorption and cholesterol excretion. Cholic acid has orally activity^[1]^[2].
Molecular Weight	809.11
Formula	C₄₂H₇₂N₄O₉S
Appearance	Solid
Color	White to off-white
SMILES	O=C1N[C@H]2[C@H](CS[C@H]2CCCCC(NCCOCCOCCOCCNC(CC[C@@H](C)[C@@]3([H])CC[C@@]4([H])[C@]5([H])[C@H](O)C[C@]6([H])C[C@@H](CC[C@]6(C)[C@@]5([H])C[C@H](O)[C@]34C)O)=O)=O)N1
Shipping	Room temperature in continental US; may vary elsewhere.
Storage	-20°C, protect from light *In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
Purity & Documentation	Purity: ≥95.0% Select Batch: Data Sheet (263 KB) SDS (251 KB) COA (242 KB) HNMR (271 KB) Handling Instructions (2659 KB)
References	[1]. Li Y, et al. Mechanism of hepatic targeting via oral administration of DSPE-PEG-Cholic acid-modified nanoliposomes. Int J Nanomedicine. 2017 Feb 28;12:1673-1684. [Content Brief] [2]. Pan X, et al. Cholic acid Feeding Leads to Increased CYP2D6 Expression in CYP2D6-Humanized Mice. Drug Metab Dispos. 2017 Apr;45(4):346-352. [Content Brief]